Kimia Biosciences Share Price
29.50+1.00 (+3.51%)
-18.06% past 1 Year
Laurel Organics Ltd. is a Public limited company was incorporated in September 1993 in district Gurgaon Haryana. They have manufactured more than thirty intermediates like Cardiovascular Anti-infectives Central Nervous System
Corporate filings & documents
Announcements
Outcome of the Meeting of the Board of Directors held on September 03 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
17 hours agoOutcome of the Meeting of the Board of Directors held on September 03 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
17 hours agoNewspaper publication unaudited Financial Results for the Quarter Ended 30 June 2026
3 weeks agoNewspaper publication unaudited Financial Results for the Quarter Ended 30 June 2026
3 weeks agoApproval of unaudited financial result (Standalone) for quarter ended june 30 2026.
3 weeks agoApproval of unaudited financial result (Standalone) for quarter ended june 30 2026.
3 weeks agoPursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we have enclosed herewith:1. Unaudited Financial Results for the First quarter ended June 30 2026 duly approved and taken on record by the Board of Directors at its meeting held today i.e. Monday August 10 2026. 2. Limited Review Report on the aforesaid results from Statutory Auditors of the Company as placed before the Board of Directors of the Company in its meeting held today.
3 weeks agoPursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we have enclosed herewith:1. Unaudited Financial Results for the First quarter ended June 30 2026 duly approved and taken on record by the Board of Directors at its meeting held today i.e. Monday August 10 2026. 2. Limited Review Report on the aforesaid results from Statutory Auditors of the Company as placed before the Board of Directors of the Company in its meeting held today.
3 weeks agoKimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th 2026.
1 month agoKimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th 2026.
1 month agoChange in Management appointment of Cost Auditor Internal Auditor Secretarial Auditor and Discountinuance/ Cessation of Secretarial Auditor
1 month agoOutcome of the Meeting of the Board of Directors held on August 1 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Appointment of Cost Auditor Internal Auditor and Secretarial Auditor and Discontinuance of Secretarial Auditor
1 month agoClosure of Trading window for quarter ending June 30 2026
2 months agoClosure of Trading window for quarter ending June 30 2026
2 months agoPublication of Results for quarter and year ended March 31 2026
3 months agoPublication of Results for quarter and year ended March 31 2026
3 months agoApproval of Audited standalone Financial results alongwith Audited Report thereon for financial year 2025-26
3 months agoKimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone ) for the quarter and financial year ended 31st March 2026 along with the Audit Report thereon
3 months agoAppointment of Mr. Mani Jain as CFO & KMP w.e.f. 27.04.2026
4 months agoAppointment of Mr. Mani Jain as CFO & KMP w.e.f. 27.04.2026
4 months agoOutcome of Board Meeting held on 18 April 2026 under regulation 30 of Sebi(Lodr) Regulations 2015 - Change in Management
4 months agoCompliance certificate under Reg. 74(5) of SEBI (DP)Regulations 2018 for quarter ending March 31 2026.
4 months agoWe would like to inform you that company is in compliance with provision of Reg 30 of SEBI(LODR) Regulations 2015 and has been promptly intimating to exchange all events information and announcement that may have bearing on operation and performance of the company. There is no undisclosed price sensitive information or any pending announcement/corporate action which in our opinion may have a bearing on price movement in the scrip of the company. The movement in share price is purely market driven and company has no control over the same.
4 months agoWe would like to inform you that company is in compliance with provision of Reg 30 of SEBI(LODR) Regulations 2015 and has been promptly intimating to exchange all events information and announcement that may have bearing on operation and performance of the company. There is no undisclosed price sensitive information or any pending announcement/corporate action which in our opinion may have a bearing on price movement in the scrip of the company. The movement in share price is purely market driven and company has no control over the same.
4 months agoThe Exchange has sought clarification from Kimia Biosciences Ltd on April 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoThe Exchange has sought clarification from Kimia Biosciences Ltd on April 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoIntimation of change of management under regulation 30 of SEBI LODR 2015
5 months agoIntimation of change of management under regulation 30 of SEBI LODR 2015
5 months agoIntimation of Resignation of Pallavi Garg as Company Secretary and Compliance officer of the company w.e.f. 03.04.2026.
5 months agoIntimation of Resignation of Pallavi Garg as Company Secretary and Compliance officer of the company w.e.f. 03.04.2026.
5 months agoClosure of Trading window
5 months agoClosure of Trading window
5 months agoVoting Result of Postal Ballot along with Scrutinizer Report
5 months agoResignation of Additional Director(in the category of Executive Director)
6 months agoNewspaper Publication-Postal ballot
6 months agoNewspaper Publication-Postal ballot
6 months agoIntimation of postal ballot notice
6 months agoIntimation under Regulation 30 of SEBI(Listing Obligations and Disclosures Requirement)Regulation 2015-modification in Postal Ballot notice
6 months agoNewspaper Publication for the financial results for the quarter and nine months ended 31st December 2025
6 months agoNewspaper Publication for the financial results for the quarter and nine months ended 31st December 2025
6 months agoResults for the financial for the quarter and nine months ended on 31st December 2025
6 months agoResults for the financial for the quarter and nine months ended on 31st December 2025
6 months agoBoard Meeting outcome
6 months agoBoard Meeting outcome
6 months agoAnnouncement under regulation 30 of SEBI (listing Obligations and disclosures requirement) regulations 2015-Non Applicability of Opening of Suspense Escrow Account in connection with Municipal Bond
6 months agoIntimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirement) Regulations 2015.
6 months agoKimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Board Meeting intimation for consider and approve the un-audited(standalone) Financial Results for the quarter and nine months ended on 31st December 2025
6 months agoIntimation of Resignation of Chief Financial Officer(CFO) key Managerial Personnel under Regulation 30 of SEBI(listing Obligations and Disclosure Requirements)Regulations 2015
7 months agoCertificate pursuant to Regulation 74(5) of the SEBI(Depositories and participants)Regulations 2018
7 months agoIntimation under regulation 30 of SEBI(LODR) regulations 2015-appointment of chief financial officer("CFO") Key Managerial Personnel
7 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Village Bhondsi Tehsil Sohna Gurgaon Dist Bhondsi Haryana PIN: 122102 Tel No: 09654746544 / 09654206544 Fax No: NULL Email: [email protected] Internet: www.kimiabiosciences.com
Registrars
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi Beetal House , 99 Mandangir 3rd Floor, Behind Local Shopping Centre Near Dada Harsukhdas Mandir PIN: Tel No: 011-29961281 -82 Fax No: 011-29961284 Email: NULL
Management
Sameer Goel, Chairman & Managing Director
Sameer Goel, Chairman & Managing Director
Abhishek Kumar Pandey, Company Secretary & Compliance Officer
Details
BSE 530313
NSE NULL
ISIN INE285U01025